Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance

Abstract The clinical importance of serum hepcidin in non-dialysis chronic kidney disease (CKD) patients is unclear. The database of a large-scale multicentre prospective study in Korea of 2238 patients enrolled from 2011–2016 was analysed. After excluding patients with missing serum hepcidin (n = 1...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sung Woo Lee, Jeong Min Kim, Hye Jin Lim, Young-Hwan Hwang, Soo Wan Kim, Wookyung Chung, Kook-Hwan Oh, Curie Ahn, Kyu-Beck Lee, Su Ah Sung
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3d717bc6342a4e6d9e2a4e6bb303b213
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3d717bc6342a4e6d9e2a4e6bb303b213
record_format dspace
spelling oai:doaj.org-article:3d717bc6342a4e6d9e2a4e6bb303b2132021-12-02T16:06:45ZSerum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance10.1038/s41598-017-04664-y2045-2322https://doaj.org/article/3d717bc6342a4e6d9e2a4e6bb303b2132017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04664-yhttps://doaj.org/toc/2045-2322Abstract The clinical importance of serum hepcidin in non-dialysis chronic kidney disease (CKD) patients is unclear. The database of a large-scale multicentre prospective study in Korea of 2238 patients enrolled from 2011–2016 was analysed. After excluding patients with missing serum hepcidin (n = 125) and haemoglobin (n = 23) levels, the study included 2090 non-dialysis CKD patients. Markers of inflammation and iron status were positively associated with serum hepcidin level, regardless of CKD stage. However, estimated glomerular filtration rate was inversely associated with serum hepcidin level, particularly in patients with CKD stages 3b–5 but not in those with CKD stages 1–3a. Use of erythropoiesis-stimulating agents was associated with increased serum hepcidin levels, particularly in patients with CKD stages 3b–5 but not in those with CKD stages 1–3a, and serum hepcidin levels positively correlated with the dose of erythropoiesis-stimulating agent. These findings suggest that serum hepcidin may be a uremic toxin and play an important role in erythropoietin resistance. However, future prospective studies are needed to confirm our results.Sung Woo LeeJeong Min KimHye Jin LimYoung-Hwan HwangSoo Wan KimWookyung ChungKook-Hwan OhCurie AhnKyu-Beck LeeSu Ah SungNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sung Woo Lee
Jeong Min Kim
Hye Jin Lim
Young-Hwan Hwang
Soo Wan Kim
Wookyung Chung
Kook-Hwan Oh
Curie Ahn
Kyu-Beck Lee
Su Ah Sung
Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
description Abstract The clinical importance of serum hepcidin in non-dialysis chronic kidney disease (CKD) patients is unclear. The database of a large-scale multicentre prospective study in Korea of 2238 patients enrolled from 2011–2016 was analysed. After excluding patients with missing serum hepcidin (n = 125) and haemoglobin (n = 23) levels, the study included 2090 non-dialysis CKD patients. Markers of inflammation and iron status were positively associated with serum hepcidin level, regardless of CKD stage. However, estimated glomerular filtration rate was inversely associated with serum hepcidin level, particularly in patients with CKD stages 3b–5 but not in those with CKD stages 1–3a. Use of erythropoiesis-stimulating agents was associated with increased serum hepcidin levels, particularly in patients with CKD stages 3b–5 but not in those with CKD stages 1–3a, and serum hepcidin levels positively correlated with the dose of erythropoiesis-stimulating agent. These findings suggest that serum hepcidin may be a uremic toxin and play an important role in erythropoietin resistance. However, future prospective studies are needed to confirm our results.
format article
author Sung Woo Lee
Jeong Min Kim
Hye Jin Lim
Young-Hwan Hwang
Soo Wan Kim
Wookyung Chung
Kook-Hwan Oh
Curie Ahn
Kyu-Beck Lee
Su Ah Sung
author_facet Sung Woo Lee
Jeong Min Kim
Hye Jin Lim
Young-Hwan Hwang
Soo Wan Kim
Wookyung Chung
Kook-Hwan Oh
Curie Ahn
Kyu-Beck Lee
Su Ah Sung
author_sort Sung Woo Lee
title Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
title_short Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
title_full Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
title_fullStr Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
title_full_unstemmed Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
title_sort serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/3d717bc6342a4e6d9e2a4e6bb303b213
work_keys_str_mv AT sungwoolee serumhepcidinmaybeanoveluremictoxinwhichmightberelatedtoerythropoietinresistance
AT jeongminkim serumhepcidinmaybeanoveluremictoxinwhichmightberelatedtoerythropoietinresistance
AT hyejinlim serumhepcidinmaybeanoveluremictoxinwhichmightberelatedtoerythropoietinresistance
AT younghwanhwang serumhepcidinmaybeanoveluremictoxinwhichmightberelatedtoerythropoietinresistance
AT soowankim serumhepcidinmaybeanoveluremictoxinwhichmightberelatedtoerythropoietinresistance
AT wookyungchung serumhepcidinmaybeanoveluremictoxinwhichmightberelatedtoerythropoietinresistance
AT kookhwanoh serumhepcidinmaybeanoveluremictoxinwhichmightberelatedtoerythropoietinresistance
AT curieahn serumhepcidinmaybeanoveluremictoxinwhichmightberelatedtoerythropoietinresistance
AT kyubecklee serumhepcidinmaybeanoveluremictoxinwhichmightberelatedtoerythropoietinresistance
AT suahsung serumhepcidinmaybeanoveluremictoxinwhichmightberelatedtoerythropoietinresistance
_version_ 1718384836942495744